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Abstract
Background: Cytotoxicity assays have been used by researchers to screen for cytotoxicity in compound libraries.
Researchers can either look for cytotoxic compounds or screen “hits” from initial high-throughput drug screens for
unwanted cytotoxic effects before investing in their development as a pharmaceutical. These assays may be used as
an alternative to animal experimentation and are becoming increasingly important in modern laboratories. However,
the execution of these assays in large scale and different laboratories requires, among other things, the management
of protocols, reagents, cell lines used as well as the data produced, which can be a challenge. The management of all
this information is greatly improved by the utilization of computational tools to save time and guarantee quality.
However, a tool that performs this task designed specifically for cytotoxicity assays is not yet available.
Results: In this work, we have used a workflow based LIMS – the Flux system – and the Together Workflow Editor
as a framework to develop FluxCTTX, a tool for management of data from cytotoxicity assays performed at
different laboratories. The main work is the development of a workflow, which represents all stages of the assay
and has been developed and uploaded in Flux. This workflow models the activities of cytotoxicity assays
performed as described in the OECD 129 Guidance Document.
Conclusions: FluxCTTX presents a solution for the management of the data produced by cytotoxicity assays performed
at Interlaboratory comparisons. Its adoption will contribute to guarantee the quality of activities in the process of
cytotoxicity tests and enforce the use of Good Laboratory Practices (GLP). Furthermore, the workflow developed is
complete and can be adapted to other contexts and different tests for management of other types of data.
Background
Cytotoxicity is the quality of being toxic to cells. Examples
of toxic agents are some types of venom (e.g. from the
puff adder or brown recluse spider). Treating cells with
the cytotoxic compound can result in a variety of cell
fates: The cells may undergo necrosis, stop actively grow-
ing and dividing or activate a genetic program of con-
trolled cell death (apoptosis). Cytotoxicity assays are the
tests used by researchers to screen for cytotoxicity in com-
pound libraries. Researchers can either look for cytotoxic
compounds, if they are interested in developing a thera-
peutic that targets rapidly dividing cells or they can screen
“hits” from initial high-throughput drug screens for
unwanted cytotoxic effects before investing in their devel-
opment as a pharmaceutical.
Cytotoxicity tests may be used as a substitute to in vivo
tests that use animals. The concept of using in vitro cyto-
toxicity data to determine the starting doses for rodent
acute oral toxicity tests was discussed and evaluated at an
International Workshop on In Vitro Methods for Asses-
sing Acute Systemic Toxicity convened in 2000 [1]. The
approach involves using an IC50 value from an in vitro
basal cytotoxicity test with the Registry of Cytotoxicity
(RC) regression to predict an LD50 value for use as a start-
ing dose for the Acute Toxic Class (ATC) method or the
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Up-and-Down Procedure (UDP) test method [2]. Simula-
tions showed that using in vitro cytotoxicity assays to esti-
mate an LD50 to use as a starting dose in the UDP could
potentially reduce animal use by 25-40%. Additionally, sev-
eral tests have currently demonstrated the efficiency and
effectiveness of alternative methods testing to reduce,
refine, and/or replace the use of animals in testing [1-5].
However, to rely on these assays it is very important
that quality is assured for all tests through a well-
designed Quality Management System (QMS) which
includes tools to register and verify the information
regarding the tests. For research laboratories two impor-
tant QMS are the management systems from the Inter-
national Organization for Standardization (ISO) and the
Good Laboratory Practices (GLP). Good Laboratory
Practices are defined by the Organization for Economic
Cooperation and Development (OECD) as “a quality
system concerned with the organizational process and
the conditions under which non-clinical health and
environmental safety studies are planned, performed,
monitored, recorded, archived and reported” [6,7]. The
purpose of the GLP principles is to promote the devel-
opment of quality test data and provide a tool to ensure
a sound approach to the management of laboratory stu-
dies, including conduct, reporting and archiving. The
GLP principles may be considered as a set of standards
for ensuring the quality, reliability and integrity of stu-
dies, the reporting of verifiable conclusions and the tra-
ceability of data. The ISO management systems provide
a model to follow when setting up and operating a
laboratory according to a set of standards internationally
recognized. They are the result of international, expert
consensus and therefore offer the benefit of global man-
agement experience and good practice [8].
The recognition of compliance to the quality manage-
ment principles by laboratories can be complex. This
process can be slow and costly, potentially requiring
changes in laboratory routine. Recognition and mainte-
nance of compliance to these principles is also difficult
because it requires that the laboratory maintains a conti-
nuing routine of activities that include staff training,
maintenance of facilities and equipment, monitoring the
quality of the documents and lab records, calendar
inspections and periodic reporting. Manual capture, cal-
culation and verification of raw data result in a tremen-
dous drain on human resources while also jeopardizing
the integrity of the information. The administration of
paper records is particularly inefficient and expensive
and data cannot be easily integrated with other technolo-
gies. As a result, complying with the strict principles of
quality systems can be a very time consuming and expen-
sive process. Thus, the use of computer systems capable
of addressing the complexity of the regulations, ensuring
compliance with current best practice and satisfying the
concerns and expectations of the regulators is pressing.
The main tools that can assist in this process are the
Laboratory Information Management Systems (LIMS),
which allow the recording of lab activities in a complete
and easy way. All the data are recorded in databases, the
relationship between the experimental steps is logged,
allowing the traceability of samples and its chain of cus-
tody, reagents and results [9,10]. An extensive list of
LIMS can be found nowadays and several LIMS are cur-
rently available as academic, proprietary and open source
solutions. Some examples of these include SQL LIMS
[11], Lab-Soft [12], LabWare [13], FreeLIMS [14], Bio-
tracker [15], Watson [16] and the systems developed by
Hendrick [17], Quo [18], Tharayil [19] and Sanchez [20].
One of the main difficulties to implement a LIMS is
the fact that each laboratory has a different routine of
experimentation that changes over time. Therefore some
LIMS propose a customization to adequate the LIMS
general structure to the needs of the laboratory [15,16].
However, this customization can be time consuming
and may sometimes not address all the needs of a speci-
fic laboratory, such as those performing the cytotoxicity
tests. Moreover, although a significant number of LIMS
are available today, none of them addresses specifically
the information on cytotoxicity assays and therefore
more general ones are used to store these data, but typi-
cally the analysis is performed manually through inde-
pendent analysis tools [21]. Other works mention
cytotoxicity assays being managed by in-house LIMS,
being therefore unavailable for comparison [22]. There
are LIMS that provide some functionality for cytotoxi-
city data, such as the one provided by Thermo Scientific,
which provide an image analysis application [23]. In
these cases, however, the LIMS is not used for a com-
plete cytotoxicity analysis, only for part of it.
This work proposes the use of a workflow based LIMS –
the Flux system – and the Together Workflow Editor as
a framework to develop FluxCTTX, a tool for manage-
ment of data from cytotoxicity assays performed at dif-
ferent laboratories. The main work is the development of
a workflow, which represents all stages of the assay and
has been developed and uploaded in Flux. This workflow
models the activities of cytotoxicity assays performed as
described in the OECD 129 Guidance Document [6], and
guarantees that experiments performed adhere to the
GLP principles.
Methods
The design and construction of FluxCTTX involved the
use of a LIMS (with an associated database server) as an
engine and a workflow editor to construct the forms for
the interface.
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The Flux System
Flux is a LIMS that has been constructed using Java
technology and uses MySQL as a database server and
Apache Tomcat as a Web server. The system has a web
interface which is platform-independent and can be
accessed using the main browsers (Internet Explorer,
Google Chrome, Mozilla Firefox and Safari). Workflow
files are uploaded in the system through its web inter-
face. The activities created in the workflow construction
are then interpreted by the system as links.
The workflow CTTX has been constructed using the
Together Workflow Editor (TWE) [24] in the XML Pro-
cess Definition Language (XPDL) file format. The Flux
system is able to represent different workflows modeled
in TWE in the XPDL format according to the needs of
each experimental design. In Flux the protocols are
defined as processes that are composed of steps, referred
to as activities. An activity represents events of a process
and, as such, has transitions, actors and rules. This infor-
mation is represented as attributes in the workflow defi-
nition. Therefore, the user can define the characteristics
of the attributes of each activity, such as its types, the
range of values that each attribute can assume, its for-
mats or even define auto-calculated attributes derived
from other attributes. In TWE, inputs and outputs of
each activity are also defined, including the relation of
these with the experiments. During workflow definition it
is also possible to assign to each activity a documentation
that contains standard protocols, instruments calibration,
procedures and records associated with the activities.
All the information regarding the activities and attributes
is stored in a entity-relationship database through an activ-
ities table that stores all the data, using metadata to indi-
cate, whenever necessary, to which experiment or activity
each data belongs to. A simplified entity-relationship
diagram for this is showed in Figure 1.
The cytotoxicity assay modeled in FluxCTTX
The cytotoxicity assay modeled in FlucCTTX was the
Neutral Red Uptake (NRU) in vitro basal cytotoxicity
assay procedure described by the OECD 129 Guidance
Document on Using Cytotoxicity Tests for Estimate Start-
ing doses for Acute Oral Systemic Toxicity Tests [6]. The
test is based on the ability of viable cells to incorporate
and bind neutral red (NR), a supravital dye. Toxicants
can alter cell surface or lysosomal membranes that
causes cell death and or cell growth inhibition, which
decreases the amount of NR retained by the culture.
The concentration of NR dye desorbed from the cul-
tured cells is directly proportional to the number of
Figure 1 FluxCTTX database scheme.
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living cells, so cytotoxicity is expressed as a concentra-
tion-dependent reduction of the uptake of NR after che-
mical exposure. The NRU assay uses a 96-well plate
format that is reproduced in the system. The light
absorption (Optical density - OD) at 540 nm within
60 minutes of adding NR is measured using microtiter
plate reader (spectrophotometer) using blank as refer-
ence. Values of OD are registered in the system and the
averages for OD of the blank are calculated. Two con-
trols are present in the test: (i) a Positive Control(PC)
where the test is performed using Sodium dodecyl sul-
phate (SDS) as test substance to obtain a complete
dose-response curve and (ii) a Vehicle Control(VC), that
consists of routine culture medium when the test sub-
stances are dissolved in culture medium. Cell viability is
calculated automatically by the system for each test well as
percent of the mean VC at OD540. The IC50 of the test
substance is automatically calculated by the system using
the statistical package R, using a Hill function analysis of
the replicate cell viability data for each concentration.
The Construction of the CTTX workflow
The development of FluxCTTX consisted of the construc-
tion of the CTTX workflow and its upload to the LIMS
Flux. The instructions for the cytotoxicity assay of the
OECD 129 Guidance Document have been used for the
workflow construction. Information regarding the set up of
the assay as well as its results have been described in the
systems as attributes that are detailed according to the
information stored. There are several different types of
attributes, each fulfilling a specific need in storing and
managing the data. In this workflow each activity corre-
sponds to an experimental step, and its attributes identify
the types of information that are generated in this experi-
mental step. The sequence of activities then contain all the
steps of assays performed. The attributes in each activity
store the specific information of that activity. As a
consequence, the workflow has the complete description of
the data being managed, all the steps and for each step all
the required data. Because of this, the FluxCTTX system
has been fully developed by specifying the workflow, with-
out need to change the code of the LIMS. Other workflows,
or adaptations to this workflow can be developed by chan-
ging the workflow files in the editor, without changing the
Flux system. The information managed by the FluxCTTX
system is completely contained in its workflow, the Flux
system is the engine that drives the workflow. It is used to
exhibit the information contained in the workflow, that is
self-contained in the same way as a spreadsheet or text file.
The file contains the data and all of the formulas that are
required to understand it and FluxCTTX is an engine to
understand and process these data. Moreover, for those
attributes that represent results of calculations, the system
performs those, automatically preventing human errors.
Results
The FluxCTTX workflow has been developed using TWE
and has 4 main activities, representing the steps of
the OECD129 protocol and 3 child activities (Figure 2).
The first activity – Laboratory identification –identifies
the laboratory, the test performed, reagents used and team
involved in the procedure. The following activities keep
the information regarding the range finder for the test
substance, the test itself (IC50) and the positive control.
These forms have the information on samples used and
the values of optical density (OD) at 540 nm for the tests,
including the corrected OD, calculated by the system sub-
tracting the OD values obtained for the blank (average)
from those obtained for the test substance (Figure 3). The
workflow also shows the values for cell viability calculated
automatically by the system (Figure 4). Moreover, the
values of IC50 are also calculated automatically by the sys-
tem using the R package and the graphic for the calcula-
tions is exhibited (Figure 5).
Figure 2 FluxCTTX interface showing the main activities of the CTTX workflow.
Faria-Campos et al. BMC Bioinformatics 2015, 16(Suppl 19):S8
http://www.biomedcentral.com/1471-2105/16/S19/S8
Page 4 of 7
The first test of FluxCTTX has been made by inviting 5
different laboratories in Brazilian Institutions that perform
cytotoxicity assays to participate in a Interlaboratory com-
parison where the information regarding the assays was
uploaded in the FluxCTTX system. The users in these
laboratories inserted the data of the experiments performed
and checked the calculations performed by the system with
those performed manually using the Microsoft Excel
Spreadsheet. The results matched. A total of 24 assays have
been performed and the data from those uploaded in the
FluxCTTX system. The results are summarized in Table 1.
The director of the study had access to all the data
inserted in the system and was able to compare the data
inserted by the five different laboratories in a very effi-
cient and precise way.
Discussion
FluxCTTX has been used in a Interlaboratory compari-
son by five different laboratories located in three different
Brazilian states. Each laboratory has different coordina-
tors and use different experimentation techniques.
Because of this diversity, in previous laboratory compari-
sons, each has performed the experiments slightly differ-
ent than the others, and comparing the results has been
difficult. In addition to that, some laboratories have not
previously complied with the GLP principles. Due to the
lack of standardization in laboratory procedures it
became difficult not only to compare results, but also to
Figure 3 FluxCTTX interface showing form for corrected optical density (light absorption) calculations.
Figure 4 FluxCTTX interface showing form for cell viability calculations.
Figure 5 FluxCTTX interface showing a graphic for IC50
calculation constructed automatically by the system FluxCTTX
using regression calculated data without users assistance.
Table 1. Summary of FluxCTTX experiments




STDEV results of CTTX
assays
CI001 4 24.21 0.80 unsatisfactory
CI002 3 0 - unsatisfactory
CI003 15 44.12 6.08 satisfactory
CI004 2 73.3 1.09 unsatisfactory
29.03 40.1 unsatisfactory
CI005 0 0 - unsatisfactory
Lab 2 completed 3 experiments, but was unable to compute an IC50. Lab 4
reported 2 experiments, but did not use FluxCTTX.
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identify the reasons why results vary among these. IC50
values have been computed showing that FluxCTTX can
accurately compute automatically the required values
directly from the experimental data. Previously, in these
labs the experimental data had to be manually input in a
separate statistical analysis tool, potentially leading to
errors. Moreover, different tools calculate the IC50
slightly differently, leading to results that could not be
directly compared. It is important to notice that because
there are no other cytotoxicity LIMS available to the
laboratories, a direct comparison between FluxCTTX
and another CTTX LIMS is not possible. In some cases
the LIMS is not available to external users [22]. In other
cases, the systems available only automate part of the
analysis [21,23], and a manual component equivalent to
the manual analysis mentioned above is performed.
All results of the comparison have been inserted in the
system, except for one. One laboratory did not follow the
OECD 129 standard protocol for the experiments and
reported their results without using the FluxCTTX sys-
tem. The IC50 values reported by this group have had
the largest variance of all experiments, indicating that
adherence to the standard protocol increases the accu-
racy of the experiments. This is not a definite indication,
since the number of experiments was too small, but it is
a clear one, since the only lab that did not follow the pro-
tocol was the only one that was unable to analyze their
results in the system, and the one with the less accurate
results. Notice that without an integrated method of
managing the data and reporting the results, the coordi-
nator of the comparison would have to rely only on
reports sent by the laboratories. In most cases the reports
would have been different, and a comparison would be
difficult. In particular, it would be very difficult to iden-
tify that a lab did not follow the standard protocol, and
the relation between adherence to protocol and more
accurate results might not have been found.
Of the experiments uploaded in the system, not all
have been considered satisfactory. FluxCTTX managed,
however, to store data from all experiments and helped
to identify the better ones by computing the IC50 values.
It is important not only to identify the best experiments,
but also to store the unsatisfactory ones for comparison
purposes. We are currently sifting through the data
stored to identify the reasons for the success or failure of
experiments. If common patterns exist that indicate suc-
cess or failure of experiments, this information can be
used to suggest actions in future experiments to increase
the likelihood of a successful experiment.
Conclusion
In this work we present the development of the FluxCTTX
system, a LIMS designed to manage and analyze cytotoxi-
city assays performed in accordance to GLP principles and
the protocols of the OECD 129 Guidance Document.
FluxCTTX manages experimental data and analyzes them,
computing IC50 values and suggesting if the experiments
are satisfactory or not. FluxCTTX has been successfully
used in a Interlaboratory comparison with five different
laboratories, making it simpler to follow the standard pro-
tocol, to report results, and to compare these results. Future
comparisons including a larger number of laboratories are
planned, which should provide more data to be analyzed
not only to assess the effectiveness of FluxCTTX, but also
to help identifying the best experimental procedures.
The FluxCTTX system will be available at http://syrah.
luar.dcc.ufmg.br/fluxcttx [25].
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